Aging and Innate Immune Mechanisms in Pulmonary Infection

肺部感染的衰老和先天免疫机制

基本信息

  • 批准号:
    9300969
  • 负责人:
  • 金额:
    $ 41.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-15 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Older people suffer from a higher morbidity and mortality from influenza viral lung infections and secondary bacterial pneumonia than younger people. Yet the mechanisms by which aging impairs host defense to respiratory infections are not well understood. Recent human genetic studies have shown that high expression of macrophage migration inhibitory factor (MIF) alleles confer a 50% survival benefit in older individuals with community-acquired pneumonia. In support of this, our preliminary data indicate that aging is associated with reduced MIF within the aging lung in mice. Furthermore, we show that in the lungs, aging and MIF deficiency share several features: increased senescence prior to lung infection, and increased lung damage, and impaired viral clearance after influenza viral lung infection. Importantly, MIF deficiency also worsens outcomes after influenza viral infection followed by S. pneumonia bacterial infection. Here, we will investigate the mechanisms underlying MIF's effects during infectious exacerbations of the aging lung by studying genetically-defined mice infected with two clinically-relevant respiratory models: primary influenza virus, and influenza viral infection followed by S. pneumonia bacterial infection. Aim 1 will investigate mechanisms by which aging and MIF deficiency impair clearance of influenza virus with increased lung damage, with a focus on type I interferon production, an inflammatory mediator that is critical to host defense against viral infection. Aim 2 will investigate the role f MIF in host defense after secondary bacterial infection with aging. Both Aims will test the role of MIF by employing novel MIF transgenic mice and new pharmacological MIF modulators. Therefore, this proposal will yield novel information concerning how the aging lung responds to respiratory pathogens, which could provide novel information to improve therapies for older people who succumb to respiratory infections.
 描述(申请人提供):老年人流感病毒性肺部感染和继发性细菌性肺炎的发病率和死亡率高于年轻人。然而,衰老损害宿主对呼吸道感染的防御的机制还不清楚。最近的人类遗传学研究表明,高表达的巨噬细胞移动抑制因子(MIF)等位基因赋予50%的生存受益于社区获得性肺炎的老年人。为了支持这一点,我们的初步数据表明,衰老与小鼠衰老肺内MIF的减少有关。此外,我们发现,在肺部,衰老和MIF缺乏症有几个共同的特点:增加衰老前肺部感染,增加肺损伤,并削弱流感病毒肺部感染后的病毒清除。重要的是,MIF缺乏也会影响流感病毒感染后的结果,随后是S。肺炎细菌感染。在这里,我们将通过研究两种临床相关的呼吸模型感染的遗传定义的小鼠来研究MIF在老化肺的感染加重期间的作用机制:原发性流感病毒和流感病毒感染后S。肺炎细菌感染。目的1将研究衰老和MIF缺乏损害流感病毒清除并增加肺损伤的机制,重点是I型干扰素的产生,这是一种对宿主防御病毒感染至关重要的炎症介质。目的2探讨MIF在老年继发性细菌感染后宿主防御中的作用。这两个目标都将考验 通过使用新的MIF转基因小鼠和新的药理学MIF调节剂。因此,这项提案将产生关于衰老的肺如何对呼吸道病原体做出反应的新信息,这可以为改善死于呼吸道感染的老年人的治疗提供新信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD J BUCALA其他文献

RICHARD J BUCALA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD J BUCALA', 18)}}的其他基金

Defining the Pathogenic Contribution of High Genotypic MIF Expression
定义高基因型 MIF 表达的致病贡献
  • 批准号:
    10402761
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Defining the Pathogenic Contribution of High Genotypic MIF Expression
定义高基因型 MIF 表达的致病贡献
  • 批准号:
    10624334
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Defining the Pathogenic Contribution of High Genotypic MIF Expression
定义高基因型 MIF 表达的致病贡献
  • 批准号:
    10094724
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Aging and Innate Immune Mechanisms in Pulmonary Infection
肺部感染的衰老和先天免疫机制
  • 批准号:
    8967869
  • 财政年份:
    2015
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    10386832
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    8664206
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    8822823
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    9815245
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    10614419
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Inflammatory Suppression of Adaptive Immunity by Plasmodium MIF
疟原虫 MIF 对适应性免疫的炎症抑制
  • 批准号:
    9036321
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了